General and abdominal adiposity and the risk of Parkinson's disease: A prospective cohort study.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
05 2019
Historique:
received: 22 08 2018
revised: 21 01 2019
accepted: 22 01 2019
pubmed: 18 2 2019
medline: 2 6 2020
entrez: 18 2 2019
Statut: ppublish

Résumé

Due to demographic change, an increase in the frequency of Parkinson's disease (PD) patients is expected in the future and, thus, the identification of modifiable risk factors is urgently needed. We aimed to examine the associations of body mass index (BMI) and waist circumference (WC) with incident PD. In 13 of the 23 centers of the European Prospective Investigation into Cancer and Nutrition (EPIC) study, a total of 734 incident cases of PD were identified between 1992 and 2012 with a mean follow-up of 12 years. Cox proportional hazards regression was used to calculate hazard ratios (HR) with 95% confidence intervals (CI). We modelled anthropometric variables as continuous and categorical exposures and performed subgroup analyses by potential effect modifiers including sex and smoking. We found no association between BMI, WC and incident PD, neither among men nor among women. Among never and former smokers, BMI and waist circumference were also not associated with PD risk. For male smokers, however, we observed a statistically significant inverse association between BMI and PD risk (HR 0.51, 95%CI: 0.30, 0.84) and the opposite for women, i.e. a significant direct association of BMI (HR 1.79, 95%CI: 1.04, 3.08) and waist circumference (HR 1.64, 95%CI: 1.03, 2.61) with risk of PD. Our data revealed no association between excess weight and PD risk but a possible interaction between anthropometry, sex and smoking.

Identifiants

pubmed: 30772279
pii: S1353-8020(19)30019-7
doi: 10.1016/j.parkreldis.2019.01.019
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

98-104

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0500300
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : British Heart Foundation
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Lukas Riso (L)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Germany.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Germany.

Tilman Kühn (T)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Germany.

Disorn Sookthai (D)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Germany.

Lars Forsgren (L)

Department of Pharmacology and Clinical Neuroscience, Department of Biobank Research, Umeå University, Sweden.

Miles Trupp (M)

Department of Pharmacology and Clinical Neuroscience, Department of Biobank Research, Umeå University, Sweden.

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece.

Carlo La Vecchia (C)

Hellenic Health Foundation, Athens, Greece; Department of Clinical Sciences and Community Health Università degli Studi di Milano, Italy.

Anna Karakatsani (A)

Hellenic Health Foundation, Athens, Greece; 2nd Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" University Hospital, Haidari, Greece.

Diana Gavrila (D)

Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

Pietro Ferrari (P)

Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, Lyon, France.

Heinz Freisling (H)

Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, Lyon, France.

Jesper Petersson (J)

Department of Neurology, Lund University, Sweden.

Susanne Lewan (S)

Department of Neurology, Lund University, Sweden.

Roel Ch Vermeulen (RC)

Julius Centre for Public Health Sciences and Primary Care, University Medical Centre, Utrecht, the Netherlands; Institute for Risk Assessment Science, Division of Epidemiology, Utrecht University, Utrecht, the Netherlands.

Salvatore Panico (S)

Dipartimento di Medicina Clinica e Chirurgia Frederico II Univeristy, Naples, Italy.

Giovanna Masala (G)

Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute ISPO, Florence, Italy.

Eva Ardanaz (E)

CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Navarra Public Health Institute, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.

Vittorio Krogh (V)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Robert Perneczky (R)

School of Public Health, Imperial College London, UK; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.

Lefkos T Middleton (LT)

School of Public Health, Imperial College London, UK.

Olatz Mokoroa (O)

Public Health and Addictions Directorate, Basque Government, Vitoria-Gasteiz, BioDonostia Health Research Institute, Donostia-San Sebastian, Spain.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.

Sabrina Sieri (S)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Shabina A Hayat (SA)

Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom.

Carol Brayne (C)

Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom.

Elio Riboli (E)

School of Public Health, Imperial College London, UK.

Paolo Vineis (P)

School of Public Health, Imperial College London, UK.

Valentina Gallo (V)

Centre for Primary Care and Public Health, Blizard Institute, Queen Mary University of London, London, UK; School of Public Health, Imperial College London, UK.

Verena A Katzke (VA)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Germany. Electronic address: v.katzke@dkfz.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH